Skip to main content

Dr. Amy Y. Wang, MD

Hematology & Oncology (Hematology & Oncology Physician)

2650 Ridge Ave, Kellogg Cancer Center
Evanston, IL 60201

Who else practices at this address →

Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas

Call (847) 570-2112

  • Medicare participating

At a glance

Years since graduation
12
In the NPI registry since
2014
Medicare patients seen, 2024
210

Licensed in Illinois since 2018, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2014Medical school: University of Texas Medical School at Houston
  • 2014Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    IL license 036146158 (first issued 2018; active)
  • Internal Medicine Physician
    IL license 125065468

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
210
Services billed
698
Patients’ average age
77
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes19469
Established patient office or other outpatient visit, 20-29 minutes10577
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes5919
Established patient office or other outpatient visit, 40-54 minutes5534
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes4227
New patient office or other outpatient visit, 45-59 minutes3737
New patient office or other outpatient visit, 30-44 minutes3434
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2823
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes2727

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Acyclovir
Other prescribers in Evanston, IL
101
Revlimid (lenalidomide)54
Calquence (acalabrutinib maleate)35
Hydroxyurea
Other prescribers in Evanston, IL
29
Eliquis (apixaban)
Other prescribers in Evanston, IL
25
Imatinib Mesylate22
Pomalyst (pomalidomide)22
Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim)
Other prescribers in Evanston, IL
21
Dexamethasone
Other prescribers in Evanston, IL
20
Lenalidomide20

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 1 companies reported 1 payments worth $2,100 in total to this clinician.

By type
Consulting Fee$2,100

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 22, 2025Novartis Pharmaceuticals Corporation
Oct 22, 2025
Consulting Fee$2,100

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Illinois →

Industry-funded research

Named as a principal investigator on 4 industry-funded studies in 2025, from 2 companies. The companies reported $279,880 in research payments for these studies, mostly to the institutions running them.

  • A Phase 3 Randomized, Double-blind Study of Ianalumab (VAY736) Versus Placebo in Addition to Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) Who Had an Insufficient Response or Relapsed After First …
    Novartis Pharmaceuticals Corporation
  • A Phase II Multicenter, Open-label, Single-arm Dose Escalation Study of Asciminib Monotherapy in 2nd Line Chronic Phase - Chronic Myelogenous Leukemia
    Novartis Pharmaceuticals Corporation
  • Ph3 study of Pola R CHP Glofit vs PolaR CHP in 1L DLBCL
    Genentech, Inc.
  • A Phase 3, Randomized, Double-blind, Study to Assess Efficacy and Safety of Ianalumab (VAY736) Versus Placebo in Warm Autoimmune Hemolytic Anemia (wAIHA) Patients Who Failed at Least One Line of Treatment
    Novartis Pharmaceuticals Corporation

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Evanston

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 27, 2021), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1497160584. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.